identified mast cells as a predominant source of IL-17A in HS lesions, demonstrating their close interaction with IL-17 receptor-expressing keratinocytes and their role in promoting keratinocyte proliferation and disease-associated gene expression (73). This evidence concerns the gene IL17A and histiocytic sarcoma.